CS
Publications
277
Views
150,452
Downloads
31,257
Supervised works
15
1 - 277 of 277
Title Published in Access level OA Policy Year Views Downloads
Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North AmericaFrontiers in immunology
2024 212 130
Cohort profile : the Swiss Mother and Child HIV Cohort Study (MoCHiV)BMJ open
2024 7 19
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonatesClinical infectious diseases
2023 92 156
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durabilityClinical microbiology and infection
2023 120 0
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
2023 204 54
Influence of circadian clocks on adaptive immunity and vaccination responsesNature communications
2023 316 116
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonatesFrontiers in immunology
2023 137 125
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumabJAMA neurology
2022 250 175
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsScientific reports
2022 118 22
Swiss recommendations on perioperative antimicrobial prophylaxis in childrenSwiss medical weekly
2022 105 120
Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America : a molecular biomarker studyThe Lancet microbe
2022 188 126
Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controlsVaccine
2022 70 0
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence90th EAS (European Atherosclerosis Society) Congress
2022 98 0
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyClinical infectious diseases
2022 235 115
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceEuropean journal of clinical investigation
2022 449 171
Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosisInternational journal of molecular sciences
2022 274 181
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsNature communications
2022 291 209
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
2022 201 186
Is there a role for childhood vaccination against COVID-19?Pediatric allergy and immunology
2021 281 1
Human Transcriptomic Response to the VSV-Vectored Ebola VaccineVaccines
2021 161 100
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1EAS Congress 2021
2021 384 38
Rabies vaccination and multiple sclerosis relapse: A retrospective cohort studyMultiple Sclerosis and Related Disorders
2021 352 188
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
2021 441 315
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infectionClinical Microbiology and Infection
2021 527 348
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
2021 320 209
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal studyClinical Microbiology and Infection
2021 411 246
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1European Journal of Clinical Investigation
2021 424 271
Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel DiseaseDigestion
2021 152 107
Faudra-t-il vacciner les enfants contre le Covid-19 ?Revue médicale suisse
2021 84 94
Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipientsVaccine
2021 230 1
Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settingsJournal of Clinical Medicine
2021 347 227
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationNPJ Vaccines
2020 480 140
Validation of a commercially available SARS-CoV-2 serological immunoassayClinical Microbiology and Infection
2020 527 348
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid testEuropean Journal of Clinical Investigation
2020 461 475
Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid testsJournal of Clinical Medicine
2020 381 220
Risk of MS relapse after yellow fever vaccination: A self-controlled case seriesNeurology: Neuroimmunology & Neuroinflammation
2020 257 179
A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent MannerFrontiers in immunology
2020 282 159
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trialClinical Microbiology and Infection
2020 335 243
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
2020 524 225
Missed vaccinations and critical care admission: all you may wish to know or rediscover-a narrative reviewIntensive Care Medicine
2020 497 0
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology
2019 310 1
Long-term Seroprotection of Varicella-zoster Immunization in Pediatric Liver Transplant RecipientsTransplantation
2019 432 3
Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centersCell Reports
2019 330 346
Detectable Vesicular Stomatitis Virus (VSV)-specific humoral and cellular immune responses following VSV-Ebola virus vaccination in humansThe Journal of Infectious Diseases
2019 249 242
Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort studyRheumatology
2019 311 0
Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidatesAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
2019 452 3
Neonatal T follicular helper cells are lodged in a pre-T follicular helper stage favoring innate over adaptive germinal center responsesFrontiers in Immunology
2019 355 250
Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantationAmerican Journal of Transplantation
2019 527 14
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical TrialClinical Infectious Diseases
2019 327 361
Site-specific DC surface signatures influence CD4+ T cell co-stimulation and lung-homingFrontiers in Immunology
2019 295 285
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including FormulationFrontiers in Immunology
2019 280 331
Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prisonJournal of Global Health
2018 432 293
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlanFrontiers in Immunology
2018 500 617
Prévention de la grippe en milieu de soins aigus : une intervention multimodaleRevue médicale suisse
2018 472 304
Correlates of vaccine-induced protective immunity against Ebola virus diseaseSeminars in Immunology
2018 680 478
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccinationNPJ Vaccines
2018 426 198
Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein 180L Single-Nucleotide Polymorphism Is Associated With Susceptibility to Recurrent Pneumococcal Lower Respiratory Tract Infections in ChildrenFrontiers in Immunology
2018 533 341
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyThe Lancet Infectious Diseases
2018 514 0
Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?Expert Review of Vaccines
2018 372 0
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and AfricaScience Translational Medicine
2017 639 2
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal ImmunizationClinical Infectious Diseases
2017 626 350
Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous surveyPLOS ONE
2017 514 239
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementationThe Journal of Maternal - Fetal & Neonatal Medicine
2017 471 0
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussisClinical infectious diseases
2016 754 5
Clinical Management of Ebola Virus Disease in the United States and EuropeNew England Journal of Medicine
2016 1,229 363
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhoodProceedings of the National Academy of Sciences of the United States of America
2016 667 2
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary ReportThe New England journal of medicine
2016 936 294
Reply to Abu Raya et alClinical infectious diseases
2016 440 3
Vaccination in early life: standing up to the challengesCurrent Opinion in Immunology
2016 514 1
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid CellsJournal of Immunology
2016 556 2
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genesThe Journal of experimental medicine
2016 791 4
The 2014–2015 Ebola outbreak in West Africa: Hands OnAntimicrobial Resistance and Infection Control
2016 548 258
Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccineVaccine
2016 590 3
Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I studyVaccine
2015 534 0
The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector ImmunogenicityJournal of virology
2015 605 2
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialLancet. Infectious diseases
2015 708 0
Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseasesSchweizerische medizinische Wochenschrift
2015 625 1
Protective efficacy of individual CD8+ T cell specificities in chronic viral infectionThe Journal of immunology
2015 635 0
Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case reportLancet. Infectious diseases
2015 715 1
Ebola vaccine R&D: Filling the knowledge gapsScience translational medicine
2015 514 1
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeThe Journal of immunology
2015 680 2
Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of conceptVaccine
2015 622 236
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted InfectionPLOS pathogens
2015 732 324
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal studyArthritis research & therapy
2015 548 583
Bordetella holmesii : an under-recognised Bordetella speciesLancet. Infectious diseases
2014 743 0
Diagnosis of whooping cough in Switzerland: differentiating Bordetella pertussis from Bordetella holmesii by polymerase chain reactionPloS one
2014 767 348
Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young childrenEuropean journal of clinical microbiology & infectious diseases
2013 702 336
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in childrenThe Pediatric infectious disease journal
2013 633 0
Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young childrenJournal of leukocyte biology
2013 778 0
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newbornThe Pediatric infectious disease journal
2013 729 3
Tetanus immunity as a surrogate for past diphtheria-tetanus-pertussis immunization in migrant childrenThe Pediatric infectious disease journal
2013 720 5
Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early lifePloS one
2013 720 452
Calendrier vaccinal InfoVac pratique 2013Archives de pédiatrie
2013 654 6
Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell nicheThe Journal of immunology
2012 612 0
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccineAntiviral therapy
2012 655 6
Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*HIV medicine
2012 616 1
Use of pneumococcal polysaccharide vaccine in children: what is the evidence?Current opinion in infectious diseases
2012 563 0
Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in SwitzerlandClinical and vaccine immunology
2012 672 0
Comparison of clinical presentation of respiratory tract infections in H1N1/09-positive and H1N1/09-negative patientsEuropean journal of pediatrics
2012 713 327
Bulletin InfoVac-FranceArchives de pédiatrie
2012 552 0
Bulletin InfoVac-FranceArchives de pédiatrie
2012 580 0
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccinePloS one
2012 777 365
Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemiaClinical microbiology and infection
2012 597 0
Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenicAmerican journal of transplantation
2012 801 2
Acceptability of maternal immunization against influenza: the critical role of obstetriciansJournal of maternal-fetal & neonatal medicine
2012 751 0
Vaccination against seasonal flu in Switzerland: The indecision of pregnant women encouraged by healthcare professionalsRevue d'épidémiologie et de santé publique
2012 730 3
Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvantsThe Journal of immunology
2012 610 0
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsHIV medicine
2012 726 0
Bulletin InfoVac-FranceArchives de pédiatrie
2012 587 0
Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference centerPediatric transplantation
2012 706 0
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analogJournal of controlled release
2012 676 1
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatientsThe oncologist
2012 697 0
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responsesThe Journal of immunology
2012 710 0
Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac diseaseJournal of pediatric gastroenterology and nutrition
2012 640 480
Vaccinologie : nouvelles recommandations pour les rappels tétanos, diphtérie et coqueluche chez l'adulteRevue médicale suisse
2012 599 2
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination programPharmacoepidemiology and drug safety
2012 627 1
Bulletin spécial calendrier vaccinalArchives de pédiatrie
2011 514 2
Bulletin InfoVac-FranceArchives de pédiatrie
2011 559 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsHaematologica
2011 1,056 668
Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticlesBioconjugate chemistry
2011 657 0
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised childrenVaccine
2011 651 0
Challenges in infant immunity: implications for responses to infection and vaccinesNature immunology
2011 481 0
Vaccination during pregnancy to protect infants against influenza: why and why not?Vaccine
2011 616 0
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyArthritis and rheumatism
2011 884 8
Bulletin spécial semaine de la vaccination: rougeole avril no 4/2011 1Archives de pédiatrie
2011 423 0
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipientsAmerican journal of transplantation
2011 668 0
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemiaPharmacogenomics
2011 960 6
Neonatal immunization: where do we stand?Current opinion in infectious diseases
2011 522 2
Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?Archives of neurology
2011 712 0
Bulletin InfoVac-FranceArchives de pédiatrie
2011 566 0
The next decade of vaccines: societal and scientific challengesLancet
2011 662 0
Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein AClinical microbiology and infection
2011 639 0
Bulletin infovacArchives de pédiatrie
2011 560 0
Improvement of measles immunity among migrant populations: lessons learned from a prevalence study in a Swiss prisonSchweizerische medizinische Wochenschrift
2011 755 1
Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experienceAgeing research reviews
2011 717 1,299
Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoquesRevue médicale suisse
2011 497 1
Mode of action of adjuvants: implications for vaccine safety and designBiologicals
2010 640 0
Vaccinologie. Questions autour de la sécurité des vaccins adjuvantes contre la grippe A(H1N1)Revue médicale suisse
2010 518 1
Glycoconjugate vaccines and immune interference: A reviewVaccine
2010 555 0
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunityNature medicine
2010 597 0
Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory?Vaccine
2010 584 0
Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measuresScandinavian journal of infectious diseases
2010 729 3
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancyThe Journal of infectious diseases
2010 559 0
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected childrenArchives of disease in childhood
2010 695 0
Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countriesMedicine
2010 624 1
Booster vaccination after neonatal priming with acellular pertussis vaccineThe Journal of pediatrics
2010 596 0
B-cell responses to vaccination at the extremes of ageNature reviews. Immunology
2009 613 0
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trialsLancet
2009 677 0
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesLancet
2009 594 0
Impaired antibody response causes persistence of prototypic T cell-contained virusPLoS biology
2009 759 774
Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature"The Journal of immunology
2009 544 0
Vaccinologie : quel rattrapage pour les patients avec des vaccinations inconnues ou incomplètes ?Revue médicale suisse
2009 511 0
Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theoriesVaccine
2009 668 0
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelinesEuropean journal of pediatrics
2009 698 0
Immunization and transplantation--what is new and what is coming?Pediatric transplantation
2009 513 0
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cellsPloS one
2009 702 433
Allergies et vaccins : distinguer le vrai du fauxRevue médicale suisse
2009 509 0
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in SwitzerlandThe Pediatric infectious disease journal
2009 691 0
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablastsBlood
2008 694 0
Recurrence of cardiorespiratory events following repeat DTaP-based combined immunization in very low birth weight premature infantsThe Journal of pediatrics
2008 604 0
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responseThe Journal of immunology
2008 604 2
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected childrenThe Pediatric infectious disease journal
2008 641 3
Rougeole : diagnostic et prise en charge d'une maladie toujours d'actualitéRevue médicale suisse
2008 671 0
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibodyClinical infectious diseases
2008 582 0
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cellsBlood
2008 674 0
Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunizationThe Journal of pediatrics
2008 588 1
Actualités vaccinologiques pour 2008: quoi de neuf en Suisse ?Revue médicale suisse
2008 487 0
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cellsEuropean Journal of Immunology
2008 597 0
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniaeVaccine
2008 654 1
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvantPloS one
2008 654 426
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infantsThe Journal of pediatrics
2008 627 0
Autoimmune diseases after adolescent or adult immunization: what should we expect?CMAJ. Canadian Medical Association journal
2007 535 298
Mechanisms underlying adverse reactions to vaccinesJournal of comparative pathology
2007 578 0
Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference centerPediatric transplantation
2007 654 0
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-upThe Journal of trauma
2007 526 0
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005Vaccine
2007 500 0
Atorvastatin treatment and vaccination efficacyJournal of clinical pharmacology
2007 613 0
Influence of anesthesia on immune responses and its effect on vaccination in children: review of evidencePaediatric anaesthesia
2007 629 2
Author's reply [Vaccination and anesthesia]Paediatric anaesthesia
2007 548 0
Vaccination des patients souffrant de maladies chroniques du foieRevue médicale suisse
2007 496 2
The challenges of vaccine responses in early life: selected examplesJournal of comparative pathology
2007 569 0
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cellsJournal of virology
2007 582 552
Vaccinologie : Plan de vaccination suisse 2007 : première lectureRevue médicale suisse
2007 498 4
Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactionsThe Pediatric infectious disease journal
2007 532 0
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?Clinical and vaccine immunology
2006 729 501
Actualités vaccinologiques 2005 : nouvelle catégorie de recommandations pour une protection vaccinale optimaleRevue médicale suisse
2006 498 0
Enhanced chickenpox exanthema in vaccine injection siteScandinavian journal of infectious diseases
2006 502 0
Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twinsVaccine
2006 558 0
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacyEuropean Journal of Immunology
2006 526 0
Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survivalThe Journal of immunology
2006 606 382
Les vaccins sous haute surveillance : effets indésirables des vaccins : questions posée et réponses apportées par InfoVacArchives de pédiatrie
2006 503 1
B. Zinka et al., Unexplained cases of sudden infant death shortly after hexavalent vaccinationVaccine
2006 636 0
Effect of month of vaccine administration on antibody responses in The Gambia and PakistanTM & IH. Tropical medicine and international health
2006 558 0
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infantsThe Journal of infectious diseases
2006 594 427
Immunisation of premature infantsArchives of disease in childhood
2006 502 0
VaccinologieRevue médicale suisse
2005 461 0
Die Folgen einer ungenügenden Herdimmunität bei «pädiatrischen» Infektionskrankheiten - Beispiel einer MasernepidemieTherapeutische Umschau
2005 666 0
How do physicians immunize their own children? Differences among pediatricians and nonpediatriciansPediatrics
2005 526 0
Can successful vaccines teach us how to induce efficient protective immune responses?Nature medicine
2005 581 0
Infections récurrentes des voies respiratoires inférieures de l'enfant : quand et comment les investiguer ?Revue médicale suisse
2005 580 0
Vaccine safety controversies and the future of vaccination programsThe Pediatric infectious disease journal
2005 640 0
La vaccinologie, une science neuve aux prises avec les croyancesRevue médicale suisse
2005 448 0
Les adjuvants vaccinaux et la myofasciite à macrophagesArchives de pédiatrie
2005 581 1
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703FEMS immunology and medical microbiology
2005 589 357
The advantage of mucosal immunization for polysaccharide-specific memory responses in early lifeEuropean Journal of Immunology
2005 438 0
Immunisation, immunomodulation et prévention des infections respiratoiresRevue médicale suisse
2005 488 0
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine SafetyAmerican journal of public health
2004 583 890
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell typeVaccine
2004 710 0
Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responsesVaccine
2004 579 0
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine responseVaccine
2004 656 0
Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory eventsThe Journal of pediatrics
2004 539 0
Genetic regulation of immune responses to vaccines in early lifeGenes and immunity
2004 556 0
Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infectionMicrobes and infection
2004 552 0
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheresThe Journal of immunology
2004 644 750
Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adultsVaccine
2004 559 0
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic miceThe Journal of immunology
2004 607 0
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeysThe American journal of tropical medicine and hygiene
2004 983 1,245
Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinantsVaccine
2003 463 0
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)Vaccine
2003 556 0
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal miceVaccine
2003 637 0
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particlesVirology
2003 619 465
Les adjuvants vaccinaux et la myofasciite à macrophagesBulletin de l'Académie nationale de médecine
2003 580 0
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidateVaccine
2003 591 0
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implicationsThe Journal of experimental medicine
2003 519 942
Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigensThe Journal of immunology
2003 554 530
Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothersThe Journal of immunology
2003 618 561
Prévention vaccinale chez les adolescents : et s'il suffisait d'y penser ?Médecine et hygiène
2003 436 2
Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cellsThe Journal of immunology
2002 574 337
Polémiques de sécurité vaccinale : fin d'une histoire ou histoire sans fin ?Médecine et hygiène
2002 380 0
Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccinesEuropean Journal of Immunology
2002 587 2
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal miceInfection and immunity
2002 537 331
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussisInfection and immunity
2002 590 337
Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infectionThe Journal of infectious diseases
2002 584 0
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccinationThe Journal of immunology
2002 566 361
Epidemiology of herpes simplex virus in children by detection of specific antibodies in salivaThe Pediatric infectious disease journal
2001 557 0
Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vectorVirology
2001 601 350
Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodiesFEMS immunology and medical microbiology
2001 544 292
Neonatal and early life vaccinologyVaccine
2001 595 0
Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early lifeEuropean Journal of Immunology
2001 487 2
The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way?Archivum Immunologiae et Therapiae Experimentalis
2001 487 0
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigensImmunology
2001 607 580
Infections récidivantes de l'enfant : quel dépistage immunitaire ?Archives de pédiatrie
2001 486 0
Nosocomial outbreak of multiple bloodborne viral infectionsThe Journal of infectious diseases
2001 708 281
How to improve communication on vaccine issues at the national level? INFOVAC-PED: an example from SwitzerlandVaccine
2001 526 0
Detection of enteroviruses in the cerebrospinal fluid by polymerase chain reaction: prospective study of impact on the management of hospitalized childrenClinical pediatrics
2000 630 0
Expression of MHC class II molecules contributes to lipopolysaccharide responsivenessEuropean Journal of Immunology
2000 476 0
Vaccin contre la fièvre jaune : formellement contre-indiqué chez les transplantésMédecine et hygiène
2000 462 0
A brief view of known landmarks reorientates path integration in hamstersNaturwissenschaften
2000 612 0
Non, le vaccin contre l'hépatite B ne provoque pas la sclérose en plaques : retour sur un psychodrame collectifLa Recherche
2000 563 1
Quand et comment vacciner les prématurés ?Médecine et hygiène
2000 394 0
Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in miceEuropean Journal of Immunology
1999 525 0
Antigen-Presentation Systems, Immunomodulators, and Immune Responses to VaccinesHandbook of experimental pharmacology
1999 384 0
Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussisLancet
1999 531 0
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal primingThe Journal of immunology
1999 489 325
Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study GroupAIDS
1998 471 0
Determinants of infant responses to vaccines in presence of maternal antibodiesVaccine
1998 485 0
Die Impfung gegen Hepatitis BSozial- und Präventivmedizin
1998 476 0
Quel avenir pour les vaccins ?Revue médicale de la Suisse romande
1998 468 0
Procalcitonin is a marker of severity of renal lesions in pyelonephritisPediatrics
1998 620 1
Hépatite B et sclérose en plaques : comment répondre aux inquiétudes du public ?Médecine et hygiène
1998 439 0
Influenza immunization: improving compliance of healthcare workersInfection control and hospital epidemiology
1998 529 0
Immunity in early lifeImmunology today
1998 490 0
New challenges for global immunizationSymposium in Immunology: Vol. VII : Vaccination
1998 487 0
Immunity in early life : an introduction [Proceedings of the International Symposium on Immunity in Early Life. Annecy, France, 17-19 November 1997]Vaccine
1998 484 0
Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?Vaccine
1998 553 0
Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in miceEuropean Journal of Immunology
1998 570 0
Vaccination des sujets présentant un problème médical : précautions, contre-indicationsRevue médicale de la Suisse romande
1998 482 0
Optimization of vaccine responses in early life: the role of delivery systems and immunomodulatorsImmunology and cell biology
1998 496 648
Maternal immunity and infant responses to immunization : actors influencing infant responsesPreclinical and clinical development of new vaccines : proceedings of a symposium, Institut Pasteur, Paris, France, 27-28 May 1997
1998 414 0
Les vaccins contre l'hépatite BSozial- und Präventivmedizin
1998 583 0
Le développement de nouveaux vaccins à usage pédiatrique : progrès et défisRevue médicale de la Suisse romande
1998 474 0
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young miceProceedings of the National Academy of Sciences of the United States of America
1998 583 745
Cervical lymphadenitis caused by Mycobacterium genavense in a healthy childThe Pediatric infectious disease journal
1996 652 0
Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promotersThe Journal of biological chemistry
1994 620 0
Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-YProceedings of the National Academy of Sciences of the United States of America
1994 608 0
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancerMolecular and cellular biology
1993 605 0
Septicémie à anaérobes après infections oropharyngées (septicémie post-angine de Lemierre): un syndrome oubliéSchweizerische medizinische Wochenschrift
1983 760 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack